Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Odonate Therapeutics (ODTC)

OTC Markets
Currency in USD
Disclaimer
17,050.000
0.000(0.00%)
Closed

ODTC Comments

big crash .. againg today... no value left here...
https://www.google.es/amp/s/seekingalpha.com/amp/news/3712695-odonate-rises-after-ikarian-capital-lifted-stake
crashing.... get out from this stock
if you wre shortet ODt 2021 start you could make tons of money
ODT still crashing looks so bad
Go up soon;)
EPS missed, going future dow, stay out from this
What’s going on?
its going down... all going out from this garbage stock
is it going to shut down or being merged with any other company?
not sure... but looks bad for sure
thsi company shutting down
Hold and have patience, soon they will be announcing alternative plans for Tesetaxel.... Going to be a retirement stock 😊
Any new reasches or just agonizing ?
company will close...if holders are lucky, stock goes to otc forawhile..what will %96 institutional holders do ? that s real question
 Therefore, Odonate is discontinuing the development of tesetaxel and will wind down the operations of the Company. That means company won't continue any operation. It will reduce all volume day by day. Hope it goes to OTC before delisted finally.
  let see whap will happen timmorow with the stock
any operations or just operation related to tesetaxel ? That’s a question ?
As of December 31, 38356048 shares held by Institutions. I don't think they will just give up easily.
back above 8
Lets hope.
Did you take 3 seconds thinking before writing that?
What ODT said about its main product tesetaxel: "has concluded that the clinical data package for tesetaxel is unlikely to support FDA approval." They better figure out a game plan for this price may keep dropping. Not a good buying time right now. Any increase after this is just speculation. It's a captain without a ship people. What are you paying him for? Maybe you like his sea stories of yesteryear.
wauw we just  went lower then 4 great dip let hope for 3,5 or 3 to buy big
does anyone know if theye have a prodect that can help them get back to the 10+ maybe 20+ ?
Odonate Therapeutics from a hold rating to a buy rating and set a $17.00 price objective
time to buy
I bought some, it is priced to go to 35 $, i will be selling at 13 if possible.
daamm
tesetaxel pulled
anyone knows if there is a stoc split i cant find any news from it so i ggues not pls inform me if anyone knows
H.C. Wainwright & Co upgraded ABEO to a buy while lowering price target from $11 to $8. 11/25/2020
Yael, any relation between odt and abelo ?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.